Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study

Published:2011-01 Issue:1 Volume:26 Page:41-50
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Kim Jae-Min,Kim Sung-Wan,Stewart Robert,Kim Seon-Young,Yoon Jin-Sang,Jung Sung-Won,Lee Min-Soo,Yim Hyeon-Woo,Jun Tae-Youn

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hup.1168/fullpdf

Reference41 articles.

1. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis;Cipriani;Lancet,2009

2. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms;Davidson;Depress Anxiety,2002

3. Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine;Denninger;Psychosomatics,2006

4. The WHODAS II: levelling the playing field for all disorders;Eipping-Jordan;WHO Mental Health Bull,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of vortioxetine in patients with major depressive disorder in a real-life clinical setting in India: results from an interventional, flexible-dose study;Current Medical Research and Opinion;2024-08-07

2. In-person psychoeducational intervention to reduce rehospitalizations and improve the clinical course of major depressive disorder: a non-randomized pilot study;Frontiers in Psychiatry;2024-07-09

3. Use of Serum Biomarkers to Aid Antidepressant Selection in Depressive Patients;Clinical Psychopharmacology and Neuroscience;2023-06-29

4. Mental Health Prescribers’ Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region;Pharmacogenomics and Personalized Medicine;2023-05

5. The impact of early remission on disease trajectory and patient outcomes in major depression disorder (MDD): A targeted literature review and microsimulation modeling approach based on the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study;Journal of Affective Disorders;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3